Carboxamide compounds, compositions, and methods for inhibiting parp activity
CA 2332279 A1 · Owner: Zhang, Jie · Inventors: Zhang, Jie; Li, Jia-He
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A compound of formula (I) or a pharmaceutically acceptable salt hydrate, ester, solvate, prodrug, metabolite stereoisomer, or mixtures thereof; , wherein: Y represents the atoms necessary to form a fused 5-to 6-membered aromatic or non-aromatic, carbocyclic or N-containing heterocyclic ring wherein Y and any heteroatom(s) therein are unsubstituted or independently substituted by at least one non-interfering alkyl alkenyl, cycloalkyl, cycloalkenyl, aralkyl aryl, carboxy or halo substituent; X is at the 1position of ring Y and is -COOR5 or a substituted or unsubstituted moiety selected from the group consisting of (a) (b), (c), (d), (e), (f) and (g) , wherein R7 is hydrogen alkyl, alkenyl, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 2, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 2, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 2, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.